452 related articles for article (PubMed ID: 27479040)
1. Arm lymphoedema and upper limb impairments in sentinel node-negative breast cancer patients: A one year follow-up study.
De Groef A; Van Kampen M; Tieto E; Schönweger P; Christiaens MR; Neven P; Geraerts I; Gebruers N; Devoogdt N
Breast; 2016 Oct; 29():102-8. PubMed ID: 27479040
[TBL] [Abstract][Full Text] [Related]
2. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection.
Kootstra JJ; Dijkstra PU; Rietman H; de Vries J; Baas P; Geertzen JH; Hoekstra HJ; Hoekstra-Weebers JE
Breast Cancer Res Treat; 2013 May; 139(1):125-34. PubMed ID: 23588950
[TBL] [Abstract][Full Text] [Related]
4. Long-term morbidity after a negative sentinel node in breast cancer patients.
Verbelen H; Tjalma W; Meirte J; Gebruers N
Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13077. PubMed ID: 31050088
[TBL] [Abstract][Full Text] [Related]
5. Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures.
Sagen A; Kaaresen R; Sandvik L; Thune I; Risberg MA
Arch Phys Med Rehabil; 2014 May; 95(5):875-81. PubMed ID: 24389401
[TBL] [Abstract][Full Text] [Related]
6. Shoulder Strength Changes One Year After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Patients With Breast Cancer.
Monleon S; Ferrer M; Tejero M; Pont A; Piqueras M; Belmonte R
Arch Phys Med Rehabil; 2016 Jun; 97(6):953-63. PubMed ID: 26763950
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB.
Belmonte R; Messaggi-Sartor M; Ferrer M; Pont A; Escalada F
Support Care Cancer; 2018 Sep; 26(9):3277-3287. PubMed ID: 29651594
[TBL] [Abstract][Full Text] [Related]
8. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.
Rietman JS; Geertzen JH; Hoekstra HJ; Baas P; Dolsma WV; de Vries J; Groothoff JW; Eisma WH; Dijkstra PU
Eur J Surg Oncol; 2006 Mar; 32(2):148-52. PubMed ID: 16387467
[TBL] [Abstract][Full Text] [Related]
9. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
Rietman JS; Dijkstra PU; Geertzen JH; Baas P; De Vries J; Dolsma W; Groothoff JW; Eisma WH; Hoekstra HJ
Cancer; 2003 Aug; 98(4):690-6. PubMed ID: 12910511
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
11. Arm morbidity and disability after breast cancer: new directions for care.
Thomas-Maclean RL; Hack T; Kwan W; Towers A; Miedema B; Tilley A
Oncol Nurs Forum; 2008 Jan; 35(1):65-71. PubMed ID: 18192154
[TBL] [Abstract][Full Text] [Related]
12. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance.
Leidenius M; Leivonen M; Vironen J; von Smitten K
J Surg Oncol; 2005 Oct; 92(1):23-31. PubMed ID: 16180231
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
[TBL] [Abstract][Full Text] [Related]
14. Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy - A systematic review of the literature and necessity of a randomised study.
Parks RM; Cheung KL
Breast; 2017 Jun; 33():57-70. PubMed ID: 28282588
[TBL] [Abstract][Full Text] [Related]
15. Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review.
Verbelen H; Gebruers N; Eeckhout FM; Verlinden K; Tjalma W
Breast Cancer Res Treat; 2014 Feb; 144(1):21-31. PubMed ID: 24496928
[TBL] [Abstract][Full Text] [Related]
16. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
17. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
Helms G; Kühn T; Moser L; Remmel E; Kreienberg R
Eur J Surg Oncol; 2009 Jul; 35(7):696-701. PubMed ID: 18838245
[TBL] [Abstract][Full Text] [Related]
18. Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? Five-Year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and Incidence of True Lymphedema.
Wetzig N; Gill PG; Espinoza D; Mister R; Stockler MR; Gebski VJ; Ung OA; Campbell I; Simes J
Ann Surg Oncol; 2017 Apr; 24(4):1064-1070. PubMed ID: 27848050
[TBL] [Abstract][Full Text] [Related]
19. The perioperative educational program for improving upper arm dysfunction in patients with breast cancer: a controlled trial.
Sato F; Ishida T; Ohuchi N
Tohoku J Exp Med; 2014 Feb; 232(2):115-22. PubMed ID: 24561542
[TBL] [Abstract][Full Text] [Related]
20. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]